Back to search

Article

GLP-1 Receptor Agonists and Cardiovascular Events During Androgen Receptor Pathway Inhibitor Therapy

2026-06-02

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> Androgen receptor pathway inhibitors (ARPIs) have transformed the treatment of high risk and metastatic prostate cancer, though are associated with increased cardiovascular risk. Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have been shown to reduce cardiovascular events in non-cancer populations, but their role in patients receiving ARPIs is unclear. <h4>Methods</h...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
98cb6b72-4677-5bba-a46d-7b9c1374e1b0
DOI
10.64898/2026.05.26.26353962
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 8 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
GLP-1 Receptor Agonists and Cardiovascular Events During Androgen Receptor Pathway Inhibitor TherapyDOI 10.64898/2026.05.26.26353962
Select a neighboring publication to make it the new centre.